🇺🇸 FDA
Patent

US 6869924

Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human body, and the cloning of full length cDNA thereof

expired A61KA61K38/00

Quick answer

US patent 6869924 (Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human body, and the cloning of full length cDNA thereof) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Mar 22 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/00